C4d as a Diagnostic Tool in Proliferative GN
- 1 November 2015
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of the American Society of Nephrology
- Vol. 26 (11), 2852-2859
- https://doi.org/10.1681/asn.2014040406
Abstract
Proliferative GN is classified as immune complex-mediated or complement-mediated (C3 glomerulopathy). Immune complex-mediated GN results from glomerular deposition of immune-complexes/Ig and C3; the C3 is derived from activation of the classical and/or lectin pathways of complement. C3 glomerulopathy results from deposition of C3 and other complement fragments with minimal or no deposition of immune complexes/Ig; the C3 is derived from activation of the alternative pathway of complement. C4d is a byproduct of activation of the classic and lectin pathways. Although widely used as a marker for antibody-mediated rejection, the significance of C4d in C3 glomerulopathy is undetermined. We studied glomerular C4d staining in 18 biopsy specimens of immune-complex GN, 30 biopsy specimens of C3 GN, and 13 biopsy specimens of postinfectious GN. All specimens of immune complex-mediated GN, except two specimens of IgA nephropathy and one specimen of sclerosing membranoproliferative GN, showed bright (2-3+) C4d staining. The staining pattern of C4d mirrored the staining patterns of Ig and C3. Conversely, C4d staining was completely negative in 24 (80%) of 30 specimens of C3 glomerulopathy, and only trace/1+ C4d staining was detected in six (20%) specimens. With regard to postinfectious GN, C4d staining was negative in six (46%) of 13 specimens, suggesting an abnormality in the alternative pathway, and it was positive in seven (54%) specimens. To summarize, C4d serves as a positive marker for immune complex-mediated GN but is absent or minimally detected in C3 glomerulopathy.Keywords
This publication has 34 references indexed in Scilit:
- Pros and cons for C4d as a biomarkerKidney International, 2012
- Proliferative Glomerulonephritis Secondary to Dysfunction of the Alternative Pathway of ComplementClinical Journal of the American Society of Nephrology, 2011
- Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritisThe Lancet, 2010
- Proliferative Glomerulonephritis with Monoclonal IgG DepositsJournal of the American Society of Nephrology, 2009
- Deposition of Complement Product C4d in Anti–Glomerular Basement Membrane GlomerulonephritisAmerican Journal of Kidney Diseases, 2009
- Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndromeJournal of Medical Genetics, 2006
- Immunofluorescence on pronase-digested paraffin sections: A valuable salvage technique for renal biopsiesKidney International, 2006
- Evidence of lectin complement pathway activation in poststreptococcal glomerulonephritisKidney International, 1999
- The Current Spectrum of Infectious Glomerulonephritis: Experience with 76 Patients and Review of the LiteratureMedicine, 1995
- Glomerular Deposition of C4 Cleavage Fragment (C4d) and C4-Binding Protein in Idiopathic Membranous GlomerulonephritisNephron, 1989